XML 12 R2.htm IDEA: XBRL DOCUMENT v3.25.2
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Jun. 30, 2025
Dec. 31, 2024
CURRENT ASSETS    
Cash and cash equivalents $ 119,774,840 $ 233,318,766 [1]
Short-term investments 21,303,330 22,304,829 [1]
Accounts receivable, net 372,961,789 295,344,353 [1]
Inventories, net 475,719,663 436,497,445 [1]
Prepaid expenses and other 72,217,004 49,862,777 [1]
Total current assets 1,061,976,626 1,037,328,170 [1]
PLANT AND EQUIPMENT—NET 783,863,952 728,481,467 [1]
OTHER ASSETS    
Goodwill 340,668,927 340,668,927 [1]
Long-term investments 267,045,895 339,604,044 [1]
Intangible assets, net 186,550,142 195,157,160 [1]
Deferred tax asset 90,692,041 53,154,832 [1]
Patents and other assets, net 83,019,753 66,426,375 [1]
Total other assets 967,976,758 995,011,338 [1]
TOTAL ASSETS 2,813,817,336 2,760,820,975 [1]
CURRENT LIABILITIES    
Accounts payable 204,675,277 168,314,912 [1]
Short-term debt 3,932,497 0 [1]
Accrued liabilities 128,326,091 84,377,764 [1]
Total current liabilities 336,933,865 252,692,676 [1]
OTHER NON-CURRENT LIABILITIES 43,755,486 36,028,644 [1]
TOTAL LIABILITIES 380,689,351 288,721,320 [1]
REDEEMABLE NON-CONTROLLING INTEREST 2,490,261 0
SHAREHOLDERS’ INVESTMENT    
Common stock 13,171,245 13,632,448 [1]
Additional paid-in capital 998,911,809 1,010,440,420 [1]
Retained earnings 1,421,351,763 1,450,287,128 [1]
Accumulated other comprehensive loss (3,396,649) (6,409,341) [1]
TOTAL GENTEX CORPORATION SHAREHOLDERS' INVESTMENT 2,430,038,168 2,467,950,655 [1]
Non-controlling Interest 599,556 4,149,000 [1]
TOTAL SHAREHOLDERS' INVESTMENT 2,430,637,724 2,472,099,655 [1]
TOTAL LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST, AND SHAREHOLDERS' INVESTMENT $ 2,813,817,336 $ 2,760,820,975 [1]
[1] The condensed consolidated balance sheet at December 31, 2024 has been derived from the audited consolidated financial statements at that date, but does not include all of the inflation and footnotes required by accounting principles generally accepted in the United States for complete financial statements.